Skip to main content
Simran Kripalani, MD, Resident Physician, Philadelphia, PA

SimranKripalaniMD(She/Her)

[Pronunciation: sim-run]

Resident Physician Philadelphia, PA

Physician

Dr. Kripalani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kripalani's full profile

Already have an account?

  • Office

    3401 N Broad st
    Philadelphia, PA 19140
    Phone+1 445-227-4282

Summary

  • PGY-3 General Surgery Resident Physician.
    Interested in GI Surgery & Palliative Care.
    Cooper Medical School trained.
    Villanova U. Graduate.

Education & Training

  • Cooper Medical School of Rowan University
    Cooper Medical School of Rowan UniversityClass of 2022
  • Villanova University
    Villanova UniversityBS, Biology and Humanities, Peace & Justice Concentration

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2022 - 2025

Awards, Honors, & Recognition

  • Distinction in Research Cooper Medical School of Rowan University, 2022
  • Excellence in Service Learning Award Cooper Medical School, 2019-2020

Publications & Presentations

PubMed

Journal Articles

  • Intrapancreatic Accessory Spleen Diagnosed As Neuroendocrine Tumor: The Dangers of False Positives and Their Implications in Subsequent Management  
    Kripalani S, Patel V, Joneja U, et al., Cureus, 6/2021
  • The effect of COVID-19 and rise of telehealth on end-of-life conversations  
    http://cambridge.org/core/about, Palliative and Supportive Care, 1/2021

Other

Authored Content

  • You Will Be Unprepared to Face DeathOctober 2020
  • It is our job to change the rhetoric on who physicians areJune 2020

Press Mentions

  • Survival Outcomes Following Adjuvant Therapy in Patients with Clinical T2N0 Rectal Adenocarcinoma
    Survival Outcomes Following Adjuvant Therapy in Patients with Clinical T2N0 Rectal AdenocarcinomaMay 22nd, 2024
  • Temple University Hospital and Fox Chase Researchers Investigate Survival Outcomes Following Adjuvant Treatment in Clinical T2N0 Rectal Cancer Patients
    Temple University Hospital and Fox Chase Researchers Investigate Survival Outcomes Following Adjuvant Treatment in Clinical T2N0 Rectal Cancer PatientsMay 20th, 2024
  • Temple University Hospital and Fox Chase Researchers Investigate Survival Outcomes Following Adjuvant Treatment in Clinical T2N0 Rectal Cancer Patients
    Temple University Hospital and Fox Chase Researchers Investigate Survival Outcomes Following Adjuvant Treatment in Clinical T2N0 Rectal Cancer PatientsMay 20th, 2024